Ozempic, Wegovy and Mounjaro Are Changing Our Food Choices

Walk into a fast-food restaurant over the next few years and you might notice something subtle but significant: menus are shifting. Not just because of inflation or wellness trends, but also because a growing share of Canadians simply aren’t eating the way they used to.

A 2025 report from research firm Ipsos estimates that about 1.4 million Canadians are currently using GLP-1 medications. The report also notes that this number might triple by 2030. These drugs suppress appetite by slowing gastric emptying and increasing satiety. For many users, hunger fades, portion sizes shrink, and old habits — like swinging through the drive-thru — start to lose their appeal.

GLP-1 users consistently report eating less, eating less often, and opting for more nutritious foods:

These shifts challenge the traditional “supersize” culture that fast-food chains depended on for decades.

What’s Happening in the U.S. Gives a Preview for Canada

We often are able to look to our neighbours south of the border to see what’s coming.  Because GLP-1 use got its start earlier in the U.S., and has continued surging since, the corresponding data gleaned offers a useful preview for Canadians:

Taken together, these findings suggest the impact on fast-food, restaurant and grocery retail may be long-lasting. Restaurants, already known for a high rate of failure within the first 3 years of launching, are pivoting in order to respond:

Where is this all heading?

For Canadians, these changes are mostly positive. From the sounds of it, whether we’re using GLP-1 drugs or not, we will continue having easier access to better eating choices: lighter meals, smaller portions, and more emphasis on nutrition over indulgence.

If you (or someone you care about) are using a GLP-1 drug, consider:

➡️ Prioritizing protein and nutrient-dense foods to avoid unintended nutrient deficits.

➡️ Planning meals consciously.  When appetites are suppressed, it’s easy to under-eat.

➡️ Paying attention to overall dietary quality, not just portion size.

GLP-1 medications are doing far more than shaping weight-loss journeys. They may be reshaping the entire food economy. As millions of Canadians adopt these treatments, we’re likely to see lasting changes in how restaurants serve food, how people eat, and what “normal” portion sizes look like. 

Notwithstanding the cost implications of this shift, we see this as a positive shift and one that certainly plays into a society striving to live longer and healthier.

At The Health Insider, we’ll continue to track these trends and help you navigate them whether you’re using GLP-1 medications, thinking about them, or just trying to eat more mindfully in a changing food landscape.

~ Read more from The Health Insider ~


The information provided on TheHealthInsider.ca is for educational purposes only and does not substitute for professional medical advice. TheHealthInsider.ca advises consulting a medical professional or healthcare provider when seeking medical advice, diagnoses, or treatment. To read about our editorial review process click here.

Exit mobile version